Freedom Cannabis Inc., a Canadian producer of cannabis products, has signed a definitive agreement to acquire the assets of Calgary-based Boaz Pharmaceuticals Inc. The details of the agreement were not disclosed.

With 126,000 square feet of cultivation and manufacturing space, the Boaz assets are expected to double the production capacity of Freedom's existing facility and provide entrance into cannabis 2.0 products. The Boaz assets consist primarily of 44 specially repurposed shipping containers equipped with new technologies to produce superior quality crops and higher yields. The containers provide opportunities for scalability and ease of installation and allow for expansion of new cannabis strains. Each container is expected to hold approximately 850 cannabis plants and yield approximately 40,000 grams.

Key Transaction Highlights:

Full story available on Benzinga.com